Mutation,Clinical Phenotype Studied,Pathogenicity,Neuropathology,Biological Effect,Genomic Region,Mutation Type,Codon Change
A79V,Alzheimer's Disease,AD : Likely Pathogenic,Neuropathology consistent with AD.,"Increased  the Aβ42/Aβ40 ratio, and decreased the Aβ (37 + 38 + 40) / (42 + 43) and Aβ37/Aβ42 ratios in cells. Also, altered transcriptomic profiles in carrier brains and iPSC-derived neurons.",Exon 4,"Point, Missense",GCC to GTC
V82L,Alzheimer's Disease,AD : Likely Pathogenic,Unknown.,"Results were mixed. Although all indicated little or no change in Aβ42/Aβ40, one assay showed a robust increase in Aβ43 and a decrease in Aβ37, with a decreased Aβ37/Aβ42 ratio.",Exon 4,"Point, Missense",GTG to CTG
I83T,Alzheimer's Disease,AD : Pathogenic,"Unknown; MRI showed bilateral atrophy, especially in the parietal and temporal lobes in one case, and frontal and temporal atrophy in another.",Increased Aβ42/Aβ40 and decreased Aβ37/Aβ42.,Exon 4,"Point, Missense",ATC to ACC
M84V,"Alzheimer's Disease, Spastic Paraparesis",AD : Pathogenic,Neuropathology consistent with AD in 2 cases. MRI showed cortical and cerebellar atrophy in 2 cases; frontal and temporal lobe atrophy in a third case.,Increased Aβ42 and Aβ42/Aβ40 ratio in cells.,Exon 4,"Point, Missense",ATG to GTG
L85P,"Alzheimer's Disease, Corticobasal Syndrome, Myoclonus, Parkinsonism, Spastic Paraparesis","AD : Pathogenic, Corticobasal Syndrome : Not Classified",Neuropathological examination was not available. SPECT and PET showed bilateral hypoperfusion and hypometabolism in the occipital and temporal lobes.,"Increased Aβ42/Aβ40 ratio; increased Aβ42 in transfected cells. In vitro, decreased Aβ42 production and abrogated Aβ40 production.",Exon 4,"Point, Missense",CTC to CCC
P88L,Alzheimer's Disease,AD : Pathogenic,"Unknown, but CSF biomarkers were consistent with AD in 2 carriers. MRI showed cortical atrophy; FDG-PET revealed hypometabolism in putamina and temporo-parietal regions in one case, and in fronto-parietal areas, including the motor cortex, in another.","Increased ratio of Aβ42,43/Aβ40 and generation of Aβ45 and Aβ46.",Exon 4,"Point, Missense",CCT to CTT
V89L,Alzheimer's Disease,AD : Pathogenic,"Neurofibrillary tangles and neuritic plaques with dystrophic neurites corresponding to stage VI of Braak and Braak. Plaques abundant in the hippocampus, amygdala, and neocortex. Tangles abundant in the neocortex and hippocampus. Some amyloid angiopathy in cortical vessels. Moderate cortical atrophy and enlarged ventricles.|Typical Alzheimer's disease pathology.","Decreased Aβ40 and Aβ42 production; increased Aβ42/Aβ40 ratio in vitro.|Increased  the Aβ42/Aβ40 ratio in vitro, and decreased the Aβ (37 + 38 + 40) / (42 + 43) and Aβ37/Aβ42 ratios in cells.",Exon 4,"Point, Missense",GTG to TTG|GTG to CTG
C92S,Alzheimer's Disease,AD : Pathogenic,Unknown.,"Increased Aβ42/Aβ40 ratio, and Aβ42 and Aβ43 secretion in cells. Reduced Aβ37/Aβ42 ratio.",Exon 4,"Point, Missense",TGC to TCC
V96F,Alzheimer's Disease,AD : Pathogenic,"Unknown, but MRI in two cases showed brain volume loss, particularly in the hippocampus.","In cultured cells, increased Aβ42/Aβ40 ratio and decreased Aβ37/Aβ42 ratio. Inhibited endopeptidase activity.",Exon 4,"Point, Missense",GTC to TTC
V97L,Alzheimer's Disease,AD : Pathogenic,"Unknown; MRI from two mutation carriers showed enlarged lateral ventricles and atrophy of the cerebral cortex, especially the temporal lobes.","MIxed experimental results, but a detailed analysis of Aβ peptide production in cells indicated a deleterious effect with a decrease in the Aβ37/Aβ42 ratio. Alterations of other cellular functions were also reported.",Exon 4,"Point, Missense",GTG to TTG
I100F,Alzheimer's Disease,AD : Pathogenic,Unknown,"Unknown, but 5 in silico algorithms predicted damaging",Exon 4,"Point, Missense",ATT to TTT
F105I,Alzheimer's Disease,AD : Pathogenic,Unknown.,"Increased Aβ42/40 ratio and decreased Aβ37/40, Aβ37/42, and Aβ38/42 ratios in cells, indicating reduced γ-processivity. Also reduced total Aβ secretion.",Exon 4,"Point, Missense",TTT to ATT
F105V,Alzheimer's Disease,AD : Pathogenic,Unknown.,"Increased Aβ42/40 ratio and decreased Aβ37/40, Aβ37/42, and Aβ38/42 ratios in cells, indicating reduced γ-processivity. It also reduced total Aβ secretion.",Exon 4,"Point, Missense",TTT to GTT
F105L,Alzheimer's Disease,AD : Likely Pathogenic,Neuropathology consistent with AD in two carriers of F105L (nucleotide change unspecified).,"Increased Aβ42/40 ratio and decreased Aβ37/40, Aβ37/42, and Aβ38/42 ratios in cells (nucleotide change unspecified), indicating reduced γ-processivity. It also reduced total Aβ secretion.",Exon 4,,TTT to CTT
F105C,Alzheimer's Disease,AD : Pathogenic,Unknown; neuroimaging showed enlarged ventricles and atrophy in the hippocampus and frontotemporal regions.,Decreased Aβ (37 + 38 + 40) / (42 + 43) ratio.,Exon 4,"Point, Missense",TTT to TGT
G111W,Alzheimer's Disease,AD : Likely Pathogenic,Unknown,"Unknown, but multiple in silico algorithms predicted a damaging effect.",Exon 4,"Point, Missense",GGG to TGG
G111V,Alzheimer's Disease,AD : Likely Pathogenic,"Unknown, but an MRI scan of one case revealed bilateral hippocampal atrophy.","Reduced Aβ40, unchanged Aβ42, and elevated Aβ42/Aβ40 ratio in transfected cells. In silico analyses (PANTHER, Mutation Taster, and PolyPhen-2) predict probably pathogenic. ",Exon 4,"Point, Missense",GGG to GTG
L113P,"Alzheimer's Disease, Frontotemporal Dementia","AD : Pathogenic, FTD : Not Classified",AD-like plaques and tangles; CT scans showed predominant frontotemporal atrophy and SPECT showed hypoperfusion including the frontal lobes.,"Increased Aβ42/40 ratio and decreased Aβ37/40, Aβ37/42, and Aβ38/42 ratios in cells, indicating reduced γ-processivity. It also reduced total Aβ secretion.",Exon 4,"Point, Missense",CTA to CCA
Y115H,Alzheimer's Disease,AD : Pathogenic,Neuropathology consistent with AD.,"Increased Aβ42/Aβ40, decreased Aβ (37 + 38 + 40) / (42 + 43) and Aβ37/Aβ42 in cells and in vitro, indicating reduced γ-processivity. Suppressed Aβ production by wild-type PSEN1.  ",Exon 5,"Point, Missense",TAT to CAT
Y115C,Alzheimer's Disease,AD : Pathogenic,Neuropathology consistent with AD.,"Increased Aβ42:Aβ40 ratio and decreased Aβ37/40, Aβ37/42, and Aβ38/42 ratios in cells, indicating reduced γ-processivity. In cells, increased Aβ42 secretion; in vitro, decreased Aβ42, and especially Aβ40, production. Also, disruption of lysosome function and autophagy via accumulation of APP β-C-terminal fragments.",Exon 5,"Point, Missense",TAT to TGT
T116N,Alzheimer's Disease,AD : Pathogenic,Neuropathology consistent with AD.,"Increased Aβ42/40 ratio and decreased Aβ37/40, Aβ37/42, and Aβ38/42 ratios in cells and in vitro for Aβ42/40 ratio, indicating reduced γ-processivity. It also reduced total Aβ secretion in cells and production in vitro.",Exon 5,"Point, Missense",ACC to AAC
T116I,Alzheimer's Disease,AD : Pathogenic,"Unknown, but MRI and FDG-PET showed atrophy and hypometabolism in temporal and parietal regions.","Increased Aβ42/40 ratio and decreased Aβ37/40, Aβ37/42, and Aβ38/42 ratios in cells, indicating reduced γ-processivity. It also reduced total Aβ secretion.",Exon 5,"Point, Missense",ACC to ATC
P117A,"Alzheimer's Disease, Ataxia",AD : Pathogenic,Unknown.,"Increased Aβ42/40 and Aβ42/Aβ total ratios and decreased Aβ37/40, Aβ37/42, and Aβ38/42 ratios. ",Exon 5,"Point, Missense",CCA to GCA
P117S,Alzheimer's Disease,AD : Pathogenic,Neuropathology consistent with AD according to CERAD criteria; Neuronal loss estimated to be greater than 70 percent in one brain; extensive loss of white matter; active gliosis throughout the brain; Lewy bodies.,"Increased Aβ42/40 ratio and decreased Aβ37/40, Aβ37/42, and Aβ38/42 ratios in transfected cells, indicating reduced γ-processivity. Increased production of Aβ42 and Aβ43 at the expense of Aβ37 and Aβ40; Aβ38 was only moderately decreased. Reduced neurite outgrowth.",Exon 5,"Point, Missense",CCA to TCA
P117T,Alzheimer's Disease,AD : Pathogenic,Unknown,"Unknown, but 5 in silico algorithms predicted damaging. PHRED-CADD score: 26.5",Exon 5,"Point, Missense",CCA to ACA
P117R,Alzheimer's Disease,AD : Pathogenic,Unknown.,"Increased Aβ42/40 ratio and decreased Aβ37/40, Aβ37/42, and Aβ38/42 ratios in cells, indicating reduced γ-processivity. Also, affected cell cycle in immortalized patient lymphocytes.",Exon 5,"Point, Missense",CCA to CGA
P117L,Alzheimer's Disease,AD : Pathogenic,"Neuropathology consistent with AD. Unusually high amyloid burden, especially in the molecular layer of the cerebellum and in cerebellar vessels.","Increased Aβ42/40 ratio and decreased Aβ37/40, Aβ37/42, and Aβ38/42 ratios in cells; reduced ε-cleavage; Aβ49→Aβ46 and Aβ43→Aβ40 trimming. In addition, inhibited neurite outgrowth and neurofilament assembly, increased cell-cycle arrest, and decreased neuronal differentiation of progenitor cells.",Exon 5,"Point, Missense",CCA to CTA
P117Q,Alzheimer's Disease,AD : Pathogenic,"Unknown, but CSF biomarkers (Aβ42, tau, and phospho-tau) were in the AD pathological range in one case.","Unknown, but multiple in silico algorithms predicted a damaging effect.",Exon 5,"Point, Missense",CCA to CAA
T119I,Alzheimer's Disease,AD : Pathogenic,"Unknown, but in 3 cases, PiB-PET revealed amyloid in frontal, parietal, and temporal regions, and PET-FDG showed hypometabolism in 3 patients including parietal lobe, precuneus, anterior cingulate, dorsal frontal lobe, and temporal lobe. MRI showed atrophy in frontal, parietal, and temporal cortices. CSF Aβ42 was reduced in one case and CSF phospho-tau elevated in another. ","Unknown, but most in silico analyses predict it to be damaging, as do structural data. CADD-PHRED score = 24.",Exon 5,"Point, Missense",ACA to ATA
E120K,"Alzheimer's Disease, Parkinsonism, Spastic Paraparesis",AD : Pathogenic,Neuropathology consistent with AD.,"Increased Aβ42/40 ratio in cells and in vitro. In cells, also increased Aβ42/Aβ total ratio and decreased Aβ37/40, Aβ37/42, and Aβ38/42 ratios. In vitro, reduced Aβ40 and Aβ42 production. Cell data suggest reduced γ-processivity. ",Exon 5,"Point, Missense",GAA to AAA
E120G,Alzheimer's Disease,AD : Pathogenic,Frequent amyloid plaques and neurofibrillary tangles; Severe amyloid angiopathy.,"Decreased Aβ38 and Aβ40 production and Aβ38/Aβ42 ratio in patient brain sample. Increased Aβ42/40 ratio and decreased Aβ37/40, Aβ37/42, and Aβ38/42 ratios in cells, indicating reduced γ-processivity. Total Aβ secretion reduced in cells.",Exon 5,"Point, Missense",GAA to GGA
E120D,Alzheimer's Disease,AD : Pathogenic,Neuropathology consistent with AD.|Unknown.,"Increased Aβ42/40 ratio and decreased Aβ37/40, Aβ37/42, and Aβ38/42 ratios in cells, indicating reduced γ-processivity. It also reduced total Aβ secretion. In vitro, decreased Aβ42, and particularly Aβ40, production.",Exon 5,"Point, Missense",GAA to GAC|GAA to GAT
H131R,Alzheimer's Disease,AD : Likely Pathogenic,"Unknown, but PiB-PET showed extensive cortical and striatal amyloid deposition in one patient. Also, FDG-PET showed hypometabolism in precuneus and bilateral temporo-parietal region and reduced blood flow in parietal and temporal lobes. In two patients, MRI showed parietal and temporal atrophy.","Increased Aβ42/Aβ40 ratio in vitro. Also, abrogated pH-sensitivity of Aβ peptide generation in vitro. In silico algorithms predicted benign (Polyphen) and damaging (SIFT).",Exon 5,"Point, Missense",CAC to CGC
N135D,Alzheimer's Disease,AD : Pathogenic,Brain biopsy showed mild loss of neurons and secondary gliosis with multiple neuritic plaques and abundant neurofibrillary tangles.,Increased Aβ42/Aβ40 ratio in cell lines and in vitro; increases intracellular and secreted Aβ42 and decreases Aβ40 in cells; reduces both Aβ42 and Aβ40 production in vitro.,Exon 5,"Point, Missense",AAT to GAT
N135Y,Alzheimer's Disease,AD : Pathogenic,Postmortem findings consistent with AD.,Increased Aβ42/Aβ40 ratio and decreased Aβ37/Aβ42 ratio in cells. Reduced levels of secreted Aβ40.,Exon 5,"Point, Missense",AAT to TAT
N135S,Alzheimer's Disease,AD : Pathogenic,"Neuropathology consistent with AD, including widespread neurofibrillary tangles and neuritic plaques. Some cotton-wool plaques; Mild amyloid angiopathy; Corticospinal tract pathology.","Unknown, but multiple in silico algorithms predicted a damaging effect.",Exon 5,"Point, Missense",AAT to AGT
M139V,"Alzheimer's Disease, Atypical Dementia",AD : Pathogenic,Neuropathology consistent with AD.,"Increased Aβ42/Aβ40, Aβ42/Aβ38, Aβ43/Aβ40, and Aβ2-40:Aβ40; decreased Aβ (37 + 38 + 40) / (42 + 43) and Aβ37/Aβ42, Aβ38/Aβ40, Aβ38/Aβ42, Aβ40/Aβ43, and Aβ11-40/Aβ40 ratios. Decreased Aβ40, Aβ38, and Aβ37 levels, while increasing Aβ42 and Aβ43. Mutant protein levels were variable in iPSC-derived neurons suggesting protein instability.",Exon 5,"Point, Missense",ATG to GTG
M139L,Alzheimer's Disease,AD : Pathogenic,"Unknown, but MRI in two individuals revealed bilateral atrophy in the hippocampus and cerebral cortex.", Aβ40 levels moderately decreased; Aβ42/Aβ40 ratio increased in cultured cells.,Exon 5,"Point, Missense",ATG to TTG
M139T,Alzheimer's Disease,AD : Pathogenic,Unknown.,"Increased Aβ42/Aβ40 ratio and decreased Aβ (37 + 38 + 40) / (42 + 43), Aβ37/Aβ42, and Aβ38/Aβ42 ratios in cells. ",Exon 5,"Point, Missense",ATG to ACG
M139I,Alzheimer's Disease,AD : Pathogenic,Possible mislocalization of presenilin-1 protein; co-localization with tangles.,Increased Aβ42/Aβ total ratio.,Exon 5,"Point, Missense",ATG to ATC|ATG to ATA
V142F,Alzheimer's Disease,AD : Likely Pathogenic,"Unknown, but MRI showed severe cortical atrophy that was most pronounced in frontal and temporal lobes.","Predicted to be pathogenic by MutPred, SNPs&Go, MutationTaster, and SIFT.",Exon 5,"Point, Missense",GTC to TTC
V142I,Alzheimer's Disease,AD : Likely Pathogenic,Unknown,Little or no effect on Aβ42/Aβ40 and Aβ37/Aβ42 ratios in cells.,Exon 5,"Point, Missense",GTC to ATC
I143V,Alzheimer's Disease,AD : Pathogenic,"Neuropathology consistent with AD, including abundant amyloid plaques and severe neurofibrillary tangle pathology (stage VI Braak and Braak). Amyloid deposits were comprised largely of Aβ42, with little to no Aβ40. There was minimal amyloid angiopathy in vessels.",Increased Aβ42 and Aβ42/Aβ40 ratio in cells and in vitro.,Exon 5,"Point, Missense",ATT to GTT
I143F,Alzheimer's Disease,AD : Pathogenic,"Neuropathology consistent with AD, but in one case, more widespread distribution of plaques in the temporal sulcus compared with sporadic AD, and lower ratio of Ab40 to Ab42/Ab43 in plaques. Also, accelerated NFT formation and neuronal loss.",Increased Aβ42/Aβ40 and decreased Aβ (37 + 38 + 40) / (42 + 43) and Aβ37/Aβ42 indicating a deleterious effect.,Exon 5,"Point, Missense",ATT to TTT
I143N,Alzheimer's Disease,AD : Pathogenic,Unknown,Increased Aβ42/Aβ40 and decreased Aβ37/Aβ42 in cultured cells.,Exon 5,"Point, Missense",ATT to AAT
I143T,"Alzheimer's Disease, Myoclonus",AD : Pathogenic,Neuropathology consistent with AD.,Increased the Aβ42/Aβ40 ratio and decreased the Aβ (37 + 38 + 40) / (42 + 43) and Aβ37/Aβ42 ratios. ,Exon 5,"Point, Missense",ATT to ACT
I143M,Alzheimer's Disease,AD : Pathogenic,Neuropathology consistent with AD in one case.,"Unknown, but other mutations at this location alter Aβ peptide production and, in wild-type PSEN1, I143 forms part of the substrate-binding pore.",Exon 5,"Point, Missense",ATT to ATG
M146L,"Alzheimer's Disease, Pick's disease|Alzheimer's Disease",AD : Pathogenic,"Neuropathology consistent with AD in multiple affected mutation carriers. Pick bodies and Lewy body pathology, as assessed by α-synuclein staining, have been noted in some cases.|Neuropathology consistent with AD. In one case, Lewy body pathology in the amygdala, cingulate gyrus, and substantia nigra. ","Increased Aβ42, Aβ42/Aβ total, Aβ42/Aβ40 in cells and in vitro assays and decreased Aβ37/Aβ42. Impaired calcium dynamics, mitochondrial permeability, expression of synaptic and neuronal differentiation genes.",Exon 5,"Point, Missense",ATG to CTG|ATG to TTG
M146V,"Alzheimer's Disease, Frontotemporal Dementia","AD : Pathogenic, FTD : Not Classified","Variable: Neuropathology consistent with AD in some cases, but also, in at least one case, mixed pathology including frequent Aβ deposits, tangles, and Pick bodies.","Increased Aβ42/Aβ40 ratio; increased Aβ42 and Aβ43; lowered wild-type PSEN1 gene expression. Disrupted endosomes via accumulation of APP β-CTF. Disrupted calcium channels, triggered cascade resulting in altered axonal transport, damage/loss of neurites. Increased calcineurin activity, impaired trafficking of glutamate AMPA receptors. Disrupted mitochondrial function, altered trophic factor function, and cerebral blood flow.",Exon 5,"Point, Missense",ATG to GTG
M146I,Alzheimer's Disease,AD : Pathogenic,"Neuropathology consistent with AD.|Neuropathology consistent with AD in 3 cases, but more involvement of central grey areas, no vascular lesions, and very mild amyloid angiopathy.","Increased Aβ42/Aβ40 and Aβ42/Aβ38; unchanged Aβ38/Aβ40 and Aβ43/Aβ40 in iPSC-derived neurons. Altered protein stability. Also, disrupted lysosome function and autophagy seemingly due to accumulation of β-C-terminal APP fragments. (M146I, nt change unspecified).",Exon 5,"Point, Missense",ATG to ATA|ATG to ATC
T147I,Alzheimer's Disease,AD : Pathogenic,Unknown.,Unknown; predicted probably damaging in silico.,Exon 5,"Point, Missense",ACT to ATT
L153V,Alzheimer's Disease,AD : Pathogenic,Neuropathology consistent with AD in one case. ,Decreased Aβ40 and Aβ42 production in vitro.,Exon 5,"Point, Missense",CTG to GTG
Y154N,"Alzheimer's Disease, Spastic Paraparesis",AD : Pathogenic,"Unknown, MRI and SPECT showed atrophy and hypoperfusion in occipito-parietal areas and internal temporal lobe areas, including the hippocampus.","Dramatically decreased Aβ40 and Aβ42 production, as well as decreased endopeptidase activity, in vitro.",Exon 5,"Point, Missense",TAT to AAT
Y159F,Alzheimer's Disease,AD : Pathogenic,"Unknown, but CSF biomarkers suggestive of AD.",Increased Aβ2 resulting in an increased Aβ42/Aβ40 ratio in cells.,Exon 5,"Point, Missense",TAT to TTT
Y159S,Alzheimer's Disease,AD : Pathogenic,"Unknown, but MRI in one patient revealed mild atrophy of the temporal and parietal lobes, and the hippocampus.","Decreased Aβ40 and moderately increased Aβ42, resulting in a 4-fold increase in the Aβ42/Aβ40 ratio in cells.",Exon 5,"Point, Missense",TAT to TCT
H163Y,Alzheimer's Disease,AD : Pathogenic,"Typical AD neuropathology (one case); decreased glucose metabolism in presymptomatic mutation carriers, especially in the thalamus. Widespread brain amyloid (PiB-PET) and shrunken hippocampi.","Decreased CSF Aβ42 and Aβ38 levels. Increased Aβ42/Aβ total ratio when expressed in COS-1 cells co-transfected with APP695, and increased Aβ42 production in an in vitro assay using purified proteins.",Exon 5,"Point, Missense",CAT to TAT
H163R,"Alzheimer's Disease, Myoclonus",AD : Pathogenic,"Data are limited, but neuropathology consistent with AD has been observed in at least one case.","Increased total Aβ, Aβ42, and Aβ43, while reducing Aβ40 and Aβ38 production in cells; drastic reduction of Aβ42 and Aβ40 production in vitro. Affects γ-secretase-dependent neurexin processing.",Exon 5,"Point, Missense",CAT to CGT
W165G,Alzheimer's Disease,AD : Pathogenic,"Unknown; but SPECT showed slight decrease in blood flow to parieto-occipital regions and thalamus in one case. Also, EEG alterations, but normal MRI.",Increased Aβ42/40 ratio and decreased Aβ37/40 ratio in cells.,Exon 6,"Point, Missense",TGG to GGG
W165C,Alzheimer's Disease,AD : Pathogenic,"Unknown|Unknown, MRI showed diffuse cerebral and cerebellar atrophy in one case.",Increased Aβ42/40 ratio and decreased Aβ37/40 ratio in cells.|Increased the Aβ42/40 ratio and decreased the Aβ37/40 ratio in cells.,Exon 6,"Point, Missense",TGG to TGC|TGG to TGT
L166V,Alzheimer's Disease,AD : Pathogenic,"SPECT imaging performed four years after symptom onset showed temporoparietal hypoperfusion. Postmortem evaluation revealed neuropathology consistent with AD, including advanced plaques and tangles (CERAD C, Braak stage VI).",Unknown; predicted damaging in silico by multiple algorithms.,Exon 6,"Point, Missense",CTT to GTT
L166R,Alzheimer's Disease,AD : Pathogenic,Unknown; MRI in the proband showed cortical atrophy; PET showed parietal hypoperfusion.,"Unknown, but multiple in silico algorithms predicted a damaging effect.",Exon 6,"Point, Missense",CTT to CGT
L166P,"Alzheimer's Disease, Spastic Paraparesis","AD : Pathogenic, ALS-FTD : Not Classified","In one individual, numerous Aβ-positive neuritic and cotton-wool plaques throughout the cerebral cortex; abundant Aβ-positive amyloid cores in the cerebellar cortex. In another, robust amyloid pathology in the striatum and cerebellum, and asymmetric tau pathology in the primary sensorimotor cortex contralateral to the side most affected by spasticity.","Decreased Aβ (37 + 38 + 40) / (42 + 43) and Aβ37/Aβ42 and increased Aβ42/Aβ40. Increased Aβ42 and Aβ43; endosomal accumulation of APP β-CTF. Also, interfered with wild-type PSEN1 activity, reduced GLT-1 interaction, inhibited calcium leak in the ER, affected ApoE secretion, altered PSEN1 subcellular localization. Stalled γ-secretase-substrate complex tied to synaptic loss.",Exon 6,"Point, Missense",CTT to CCT
S169P,"Alzheimer's Disease, Myoclonic seizure",AD : Pathogenic,"Neuropathology consistent with AD, including numerous plaques and neurofibrillary tangles, neuritic irregularities, neuronal lipofuscin, and mild astrocytosis.",Increased Aβ42/40 ratio and decreased Aβ37/40 ratio in cells.,Exon 6,"Point, Missense",TCA to CCA
S169L,Alzheimer's Disease,AD : Pathogenic,"Neuropathology typical of AD, but also Aβ deposition in the cerebellum and white matter, as well as numerous ectopic neurons, often containing tau-immunopositive neurofibrillary tangles, in the white matter of the frontal and temporal lobes, possibly due to errant migration during development.",Increased Aβ42/40 ratio and decreased Aβ37/40 ratio in cells.,Exon 6,"Point, Missense",TCA to TTA
S170F,Alzheimer's Disease,AD : Pathogenic,"Variable: Some cases with typical AD pathology; Extensive Lewy bodies in the substantia nigra and throughout the brain have also been reported. One case had severe cerebellar pathology, including abundant amyloid deposition and loss of Purkinje cells.","Increased Aβ42/Aβ40 ratio in cells and in vitro, but effects on Aβ42 and Aβ40 levels varied between studies. Effects on calcium homeostasis, phospho-tau expression, autophagy, expression of mitochondrial fission and fusion proteins, cell viability, and trophic factor function have also been reported. ",Exon 6,"Point, Missense",TCT to TTT
L171P,Alzheimer's Disease,AD : Pathogenic,Unknown,Drastically decreased Aβ42 production and Aβ40 production was undetectable in vitro.,Exon 6,"Point, Missense",CTA to CCA
L173W,Alzheimer's Disease,AD : Pathogenic,Unknown.,Decreased Aβ40 and increased Aβ42 and the Aβ42/Aβ40 ratio in vitro.,Exon 6,"Point, Missense",TTG to TGG
L173S,Alzheimer's Disease,AD : Pathogenic,Unknown,"Unknown, predicted to be damaging by multiple in silico analyses, but not all. PHRED-CADD score=24.1",Exon 6,"Point, Missense",TTG to TCG
L173F,Alzheimer's Disease,AD : Pathogenic,Unknown; MRI from two affected mutation carriers showed atrophy of the medial temporal lobe. SPECT showed hypoperfusion of the posterior cingulate gyri and other cortical areas.|Unknown.,"Uncertain. Aβ37/Aβ42 ratio similar to control in one cell-based assay, but increased Aβ42/Aβ40 ratio in two assays. Aβ42 decreased in one assay, but increased in another.|Uncertain. Aβ37/Aβ42 ratio similar to control in one cell-based assay, but increased Aβ42/Aβ40 ratio in two assays. Aβ42 decreased in one assay, but increased in another. (One assays did not specify nucleotide change; other involved synonymous variant L173F (G>C)).",Exon 6,"Point, Missense",TTG to TTC|TTG to TTT
L174M,"Alzheimer's Disease, Cerebral Amyloid Angiopathy",AD : Pathogenic,Neuropathology consistent with AD and CAA in one case.,Decreased Aβ40 and increased Aβ42/Aβ40 ratio in in vitro experiments. Conservative mutation in third transmembrane domain.,Exon 6,"Point, Missense",CTG to ATG
L174R,Alzheimer's Disease,AD : Pathogenic,"Neuropathology consistent with AD in one case. Also, abundant Lewy bodies in amygdala and entorhinal cortex.",,Exon 6,"Point, Missense",CTG to CGG
F177L,Alzheimer's Disease,AD : Pathogenic,Unknown,Increased Aβ42 production and Aβ42/Aβ40 ratio in vitro. Little impact on total cleavage activity of γ-secretase.,Exon 6,"Point, Missense",TTT to CTT
F177V,Alzheimer's Disease,AD : Pathogenic,"Unknown, but MRI showed global brain atrophy, especially in the temporal region and hippocampus in one patient.",Increased Aβ42 and Aβ42/Aβ40 in transfected cells.,Exon 6,"Point, Missense",TTT to GTT
F177S,Alzheimer's Disease,AD : Pathogenic,"Unknown, but in one carrier, PET revealed amyloid pathology in the cortex and widespread tau pathology and hypometabolism. MRI showed whole-brain atrophy.",Increased Aβ42/Aβ40 ratio and decreased Aβ37/Aβ42 ratio in cultured cells.,Exon 6,"Point, Missense",TTT to TCT
S178P,Alzheimer's Disease,AD : Pathogenic,Unknown,"γ-secretase activity was 32% of wildtype as assessed by production levels of Aβ37, Aβ38, Aβ40, Aβ42, and Aβ43.",Exon 6,"Point, Missense",TCA to CCA
E184G,Alzheimer's Disease,AD : Likely Pathogenic,"Unknown, but MRI of one patient revelaed global cortical atrophy.","Increased Aβ42/Aβ40 ratio, with decreased Aβ42 and Aβ40 production in vitro. In silico algorithms predicted the mutation is damaging and causes structural alterations. Also, mutation is near splice site.",Exon 7,"Point, Missense",GAA to GGA
E184D,Alzheimer's Disease,"AD : Pathogenic, DLB : Not Classified, PPA : Not Classified","Neuropathology consistent with AD in three cases. In addition, CAA pathology described in two cases. Also, in two cases, robust Lewy body pathology and, in one of these cases, accumulation of the non-Aβ component of AD amyloid (NAC) in plaques and astrocytes.",Increased Aβ42/Aβ40 ratio; reduced Aβ37/Aβ42 ratio in cultured cells.,Exon 7,"Point, Missense",GAA to GAC
I202F,"Alzheimer's Disease, Cerebral Amyloid Angiopathy",AD : Pathogenic,"Neuropathology was consistent with AD, with severe CAA, in one case. CAA included included chronic inflammatory infiltrate surrounding some cortical and leptomeningeal blood vessels. Lewy pathology was found in the amygdala. ","Reduced Aβ38 and Aβ37 production, as well as Aβ38/Aβ42 and Aβ37/Aβ42 ratios in membranes isolated from patient brains and transgenic cultured cells. ",Exon 7,"Point, Missense",ATC to TTC
G206S,Alzheimer's Disease,AD : Pathogenic,Unknown; bilateral frontotemporal and parietal hypometabolism by PET; diffuse brain atrophy with enlarged ventricles by CT.,Decreased Aβ40 and Aβ42 production; increased Aβ42/Aβ40 ratio in vitro.,Exon 7,"Point, Missense",GGT to AGT
G206D,Alzheimer's Disease,AD : Pathogenic,Neuropathology consistent with AD.,Increased Aβ42 production; reduced interaction with Pen2; disrupted ER calcium homeostasis.,Exon 7,"Point, Missense",GGT to GAT
G206A,Alzheimer's Disease,AD : Pathogenic,"Typical AD neuropathology, including extensive plaques and tangles (Braak stage VI). Cortical atrophy revealed by MRI and temporo-parietal hypometabolism revealed by FDG-PET. In one case, MRI alterations were similar to those of limbic encephalitis.","Increased Aβ42/Aβ40 ratio, decreased Aβ37/Aβ42 ratio. γ-secretase activity = 61% of wildtype. ",Exon 7,"Point, Missense",GGT to GCT
G206V,Alzheimer's Disease,AD : Pathogenic,Unknown; an early MRI of the proband showed mild atrophy of the brain with normal temporal lobes.,"Increased total Aβ and Aβ42, and decreased Aβ43, Aβ40, and Aβ38 in cells.",Exon 7,"Point, Missense",GGT to GTT
G209R,Alzheimer's Disease,AD : Pathogenic,"Unknown; imaging showed mild brain atrophy in temporal lobes at early stages and diffuse brain atrophy mostly in frontotemporal lobes at advanced stages. Hypoperfusion in frontotemporal areas at early stages extending to parieto-occipital areas at advanced stages. CSF Aβ38, Aβ40, Aβ42, Aβ43 levels and Aβ43/Aβ42 were high vs other FAD carriers.",Abrogated Aβ40 production and drastically reduce Aβ42 production in vitro.,Exon 7,"Point, Missense",GGA to AGA
G209E,Alzheimer's Disease,AD : Pathogenic,"Unknown, but MRI revealed global cerebral atrophy, particularly affecting the hippocampus. FDG-PET showed global hypometabolism, particularly affecting the temporal, parietal, and occipital lobes.","Unknown, but multiple in silico algorithms predicted a damaging effect.",Exon 7,"Point, Missense",GGA to GAA
G209V,Alzheimer's Disease,AD : Pathogenic,"Neuropathology consistent with AD, includin cortical atrophy, extensive amyloid plaques and neurofibrillary tangles, and amyloid angiopathy.","Abrogated Aβ40 production and drastically reduced Aβ42 production in vitro. Also, caused incomplete endoproteolytic processing of PSEN1.",Exon 7,"Point, Missense",GGA to GTA
G209A,Alzheimer's Disease,AD : Pathogenic,Unknown; MRI showed global cortical atrophy and FDG-PET revealed widespread bilateral hypometabolism.,"Unknown; predicted likely damaging in silico by PolyPhen2, SIFT, and Provean.",Exon 7,"Point, Missense",GGA to GCA
S212Y,Alzheimer's Disease,AD : Pathogenic,"Neuropathology consistent with AD in two carriers, including neurofibrillary tangles (Braak stage VI) and frequent neuritic plaques. In one case, severe amyloid angiopathy noted in the cerebellum and occipital cortex, and α-synuclein pathology detected in the amygdala.",Aβ42/Aβ40 ratio increased and Aβ37/Aβ42 ratio decreased in cultured cells.,Exon 7,"Point, Missense",TCC to TAC
I213F,Alzheimer's Disease,AD : Pathogenic,Unknown,"Increased Aβ40 and Aβ42 secretion, and increased Aβ42/Aβ40 ratio in transfected cells.",Exon 7,"Point, Missense",ATT to TTT
I213L,Alzheimer's Disease,AD : Pathogenic,Unknown,"Increased Aβ40 and Aβ42 production, and an increase in the Aβ42:Aβ40 ratio as assessed in vitro.",Exon 7,"Point, Missense",ATT to CTT
I213T,Alzheimer's Disease,AD : Pathogenic,Unknown.,,Exon 7,"Point, Missense",ATT to ACT
H214Y,Alzheimer's Disease,AD : Pathogenic,"Unknown; imaging showed cortical atrophy, in one case more prominently in the left hemisphere, in another more marked in frontotemporal areas with white-matter lesions.",Increased Aβ42/Aβ40 and decreased Aβ37/Aβ42 in cultured cells.,Exon 7,"Point, Missense",CAC to TAC
H214N,Alzheimer's Disease,AD : Pathogenic,"Unknown; brain imaging showed cerebral atrophy in medial temporal lobes and hippocampus, and amyloid in lateral temporal-frontal-parietal areas, posterior cingulate, and precuneus. Blood Aβ oligomerization consistent with AD.",Increased Aβ42/Aβ40 and decreased Aβ37/Aβ42 ratios in cells.,Exon 7,"Point, Missense",CAC to AAC
H214R,Alzheimer's Disease,AD : Likely Pathogenic,"Unknown, but in one case, MRI showed mild white matter demyelination of the frontal and parietal lobes, with no apparent atrophy of the cerebral cortex or hippocampus.","Unknown, but multiple in silico algorithms predicted it is deleterious and structural modeling predicted alterations in the stability and position of TM helix 4.",Exon 7,"Point, Missense",CAC to CGC
G217R,Alzheimer's Disease,AD : Likely Pathogenic,Cotton wool plaques.,Increased Aβ42/Aβ40 in two cell-based assays; decreased Aβ37/Aβ42 in iPSC-derived neurons. ,Exon 7,"Point, Missense",GGT to CGT
G217D,"Alzheimer's Disease, Parkinsonism",AD : Likely Pathogenic,"Cotton wool plaques in the cortex, caudate nucleus, putamen, claustrum, thalamus, substantia innominate, and colliculi.",Decreased Aβ37/Aβ42 ratio; increased Aβ42/Aβ40. Increased Aβ43 and decreased Aβ37 production.,Exon 7,"Point, Missense",GGT to GAT
L219P,Alzheimer's Disease,AD : Likely Pathogenic,Neuropathology consistent with AD in one case; meningeal CAA in cortex and cerebellum. PET and SPECT show hypoperfusion and hypometabolism in temporal lobes and right parietal lobe.,Increased the Aβ42/Aβ40 ratio and decreased the Aβ (37 + 38 + 40) / (42 + 43) ratio.,Exon 7,"Point, Missense",CTT to CCT
Q222R,Alzheimer's Disease,AD : Likely Pathogenic,Unknown,"Increased Aβ40 and Aβ42 production, as well as the Aβ42/Aβ40 ratio in vitro.",Exon 7,"Point, Missense",CAG to CGG
Q222H,Alzheimer's Disease,AD : Likely Pathogenic,"Neuropathology consistent with AD in one case, CSF biomarkers consistent with AD in another case.","Increased Aβ42/Aβ40, decreased Aβ37/Aβ42, and increased Aβ43 levels in cultured cells.",Exon 7,"Point, Missense",CAG to CAC
Q223R,"Alzheimer's Disease, Spastic Paraparesis",AD : Pathogenic,"Unknown, but cotton-wool plaques and neurofibrillary tangles were found in two biopsies of family members of a mutation carrier. MRI of mutation carrier revealed white matter lesions in the frontotemporal region. FDG-PET showed progressive decrease in glucose metabolism in the precuneus and posterior cingulate, with parietal regions affected later. ","Increased Aβ42/Aβ40 ratio, decreased Aβ37/Aβ42 ratio, and dramatically increased Aβ43.",Exon 7,"Point, Missense",CAG to CGG
L226F,"Alzheimer's Disease, Frontotemporal Dementia",AD : Pathogenic,Neuropathology consistent with AD.,Increased Aβ42/Aβ40 ratio; increased Aβ42; increased Aβ40.,Exon 7,"Point, Missense",CTC to TTC
L226R,Alzheimer's Disease,AD : Pathogenic,"Neuropathology consistent with AD in one individual, including numerous neuritic plaques and neurofibrillary tangles in the hippocampus and neocortex.",Increased the Aβ42/Aβ40 ratio and decreased the Aβ (37 + 38 + 40) / (42 + 43) ratio.,Exon 7,"Point, Missense",CTC to CGC
I229F,Alzheimer's Disease,AD : Pathogenic,Unknown,"In vitro, increased Aβ42 production and reduced Aβ40; increased Aβ42/Aβ40 ratio",Exon 7,"Point, Missense",ATT to TTT
S230N,Alzheimer's Disease,AD : Pathogenic,"Unknown, but MRI showed diffuse atrophy, which was most severe in lateral temporal lobes and insulae.",Increased the Aβ42/Aβ40 ratio and decreased the Aβ (37 + 38 + 40) / (42 + 43) ratio.,Exon 7,"Point, Missense",AGT to AAT
A231T,Alzheimer's Disease,AD : Likely Pathogenic,Unknown,Decreased Aβ37/Aβ42; Aβ42/Aβ40 mixed results. Decreased production of all Aβ peptides.,Exon 7,"Point, Missense",GCC to ACC
A231V,Alzheimer's Disease,AD : Likely Pathogenic,Unknown,"Unknown, but multiple in silico algorithms predicted a damaging effect.",Exon 7,"Point, Missense",GCC to GTC
M233L,Alzheimer's Disease,AD : Pathogenic,Unknown; imaging showed global cerebral atrophy.,"In vitro, increased Aβ42 production, decreased Aβ40 production; increased Aβ42:Aβ40 ratio. In cells, increased Aβ42 and Aβ43, decreased total Aβ production, increased Aβ42:Aβ40 ratio. Disrupts endosomes via accumulation of APP β-CTF.",Exon 7,"Point, Missense",ATG to CTG
M233V,Alzheimer's Disease,AD : Pathogenic,"In one case: neurofibrillary tangles and amyloid plaques throughout the neocortex; occasional plaques in the spinal cord; Lewy bodies in the substantia nigra and cortex; moderate to severe amyloid angiopathy in leptomeningeal, cerebral, and cerebellar vessels. Widespread amyloid deposition in another patient as assessed by PET.",Increased Aβ42/Aβ40 ratio and decreased Aβ (37 + 38 + 40) / (42 + 43) and Aβ37/Aβ42 ratios in cells. ,Exon 7,"Point, Missense",ATG to GTG
M233T,Alzheimer's Disease,AD : Pathogenic,Neuropathology consistent with AD in at least one case.,"Increased Aβ42, Aβ48, and Aβ39; Decreased Aβ38, Aβ40, Aβ43, and Aβ46.",Exon 7,"Point, Missense",ATG to ACG
M233I,Alzheimer's Disease,AD : Pathogenic,Unknown.,Decreased the Aβ (37 + 38 + 40) / (42 + 43) and Aβ37/Aβ42 ratios; increased Aβ42/Aβ40 in two cell-based assays (variant's nucleotide change unspecified).,Exon 7,"Point, Missense",ATG to ATA
L235V,Alzheimer's Disease,AD : Likely Pathogenic,Neuropathology consistent with AD in at least one case.,"Modestly decreased Aβ (37 + 38 + 40) / (42 + 43) and Aβ37/Aβ42 ratios in cells, and increased Aβ42/Aβ40 in cells but not in vitro; deleterious effect on monoamine oxidase.",Exon 7,"Point, Missense",CTG to GTG
L235P,"Alzheimer's Disease, Myoclonus",AD : Pathogenic,Neuropathology consistent with AD.,"In transgenic mice, increased production of Aβ, increased tau hyperphosphorylation, and loss of synaptic protein. In cells, decreased Aβ (37 + 38 + 40) / (42 + 43) and Aβ37/Aβ42 ratios.",Exon 7,"Point, Missense",CTG to CCG
F237L,Alzheimer's Disease,AD : Pathogenic,"Unknown, but in one carrier CSF AD biomarkers were consistent with AD.","Decreased Aβ37/Aβ42 ratio; Aβ42/Aβ40 ratio similar to wildtype. Decreased levels of Aβ43, Aβ42, Aβ40.",Exon 7,"Point, Missense",TTT to CTT
I238M,Alzheimer's Disease,AD : Likely Pathogenic,Unknown; MRI showed progressive cerebral atrophy. PET showed hypometabolism in the frontal and temporal lobes.,Increased the Aβ42/Aβ40 ratio and decreased the Aβ (37 + 38 + 40) / (42 + 43) ratio. ,Exon 7,"Point, Missense",ATC to ATG
K239N,Alzheimer's Disease,AD : Likely Pathogenic,"Unknown, but MRI in one case showed medial temporal lobe and frontal lobe atrophy.  ","In two cell assays, Aβ42/Aβ40 was increased. In two assays, Aβ40 and Aβ42 production were decreased, but Aβ42 was increased in another. In one assay, cell survival pathways were preserved.",Exon 7,"Point, Missense",AAG to AAC
T245P,Alzheimer's Disease,AD : Likely Pathogenic,"Unknown, but MRI showed diffuse brain atrophy in one patient, and no abnormalities in 2 others.",Increased the Aβ42/Aβ40 ratio and decreased the Aβ (37 + 38 + 40) / (42 + 43) ratio.,Exon 7,"Point, Missense",ACT to CCT
A246P,Alzheimer's Disease,AD : Pathogenic,"Neuropathology consistent with AD (Braak and Braak stage VI, CERAD C) as well as cerebral amyloid angiopathy. Some α-synuclein inclusions were observed in the entorhinal cortex. Aβ42, tau, and phospho-tau levels in CSF consistent with AD",Unknown; predicted probably damaging in silico.,Exon 7,"Point, Missense",GCG to CCG
A246E,Alzheimer's Disease,AD : Pathogenic,"Generalized atrophy, most prominently in the frontal lobes and hippocampus. Neuronal loss, gliosis, neurofibrillary tangles, and plaques.","Increased Aβ42 and Aβ43 secretion, Aβ42/Aβ40 ratio, Aβ42/Aβ total ratio. Decreased production of Aβ40 and Aβ42 in vitro. Disrupts endosomes via accumulation of APP β-CTF. Impaired neuronal differentiation, neural precursor proliferation, viability, autophagy, mitophagy, lysosomal function, ER calcium flux. ",Exon 7,"Point, Missense",GCG to GAG
L248P,Alzheimer's Disease,AD : Pathogenic,Unknown.,,Exon 7,"Point, Missense",CTC to CCC
L250V,"Alzheimer's Disease, Myoclonus","AD : Likely Pathogenic, Myoclonus : Not Classified","Unknown, but MRI showed diffuse cerebral atrophy and SPECT showed severe cortical hypoperfusion","Unknown, but multiple in silico algorithms predicted a damaging effect.",Exon 7,"Point, Missense",TTG to GTG
L250S,Alzheimer's Disease,AD : Likely Pathogenic,Neuropathology consistent with AD in two cases.,"In vitro, decreases Aβ40 and Aβ42 production; increases Aβ42/Aβ40 ratio.",Exon 7,"Point, Missense",TTG to TCG
L250F,Alzheimer's Disease,AD : Pathogenic,"Unknown, but CT scans showed frontal, parietal, and temporal atrophy","Unknown, but multiple in silico algorithms predicted a damaging effect.",Exon 7,"Point, Missense",TTG to TTT
Y256N,Alzheimer's Disease,AD : Likely Pathogenic,"Unknown, but MRI revealed temporal lobe and hippocampal atrophy in one case.","Unknown, but in silico algorithms predict the mutation is deleterious.",Exon 7,"Point, Missense",TAT to AAT
Y256S,Alzheimer's Disease,AD : Likely Pathogenic,"Neuropathology consistent with AD in two cases; severe, widespread pathology, including cotton-wool plaques.","In cells, increased Aβ42 and Aβ43. Using isolated proteins, decreased production of Aβ42 and Aβ40, increased Aβ42/Aβ40 ratio.",Exon 7,"Point, Missense",TAT to TCT
A260V,Alzheimer's Disease,AD : Pathogenic,"Neuropathology consistent with AD. Also, diffuse Lewy body pathology, perivascular amyloid deposits and Pick-like intra-neuronal inclusions in the dentate gyrus.","Increased the Aβ42/Aβ40 ratio and decreased the Aβ (37 + 38 + 40) / (42 + 43) ratio. Reduced production of Aβ40 and Aβ42, disrupted APP intracellular distribution.",Exon 8,"Point, Missense",GCT to GTT
A260G,"Alzheimer's Disease, Cerebral Amyloid Angiopathy",AD : Likely Pathogenic,"Unknown, but CSF bimoarkers were consistent with AD in two patients and MRI revealed mild cortical and hippocampal atrophy in one patient and signs of CAA in two patients. ",Increased the Aβ42/Aβ40 ratio and decreased the Aβ (37 + 38 + 40) / (42 + 43) ratio.,Exon 8,"Point, Missense",GCT to GGT
V261F,"Alzheimer's Disease, Cerebral Amyloid Angiopathy, Spastic Paraparesis",AD : Likely Pathogenic,"Neuropathology consistent with AD, with cotton-wool plaques, CAA, and degeneration of spinal lateral pyramidal tracts.","Increased Aβ43 production (prevailing Aβ species) in cells. Decreased Aβ42 and Aβ40 production, and increased Aβ42/Aβ40 ratio in vitro. Also, abolished autoproteolysis.",Exon 8,"Point, Missense",GTT to TTT
L262V,"Alzheimer's Disease, Frontotemporal Dementia",AD : Likely Pathogenic,Unknown.,Unknown; predicted probably damaging in silico.,Exon 8,"Point, Missense",TTG to GTG
L262F,Alzheimer's Disease,AD : Likely Pathogenic,"A brain biopsy from one case ""confirmed the diagnosis of AD"".|Unknown.","Increased Aβ42/Aβ40 ratio in vitro, exhibiting a moderate increase in Aβ42 production, and a decrease in Aβ40 production.|Increased Aβ42/Aβ40 ratio in vitro, exhibiting a moderate increase in Aβ42 production, and a decrease in Aβ40 production (nucleotide change unspecified).",Exon 8,"Point, Missense|",TTG to TTC|TTG to TTT
C263R,Alzheimer's Disease,AD : Pathogenic,Neuropathology consistent with AD.,Decreased Aβ40 and Aβ42 production and increased Aβ42/Aβ40 ratio in vitro.,Exon 8,"Point, Missense",TGT to CGT
C263F,Alzheimer's Disease,AD : Pathogenic,"Unknown. AD-like CSF levels of Aβ40, Aβ42, Aβ43, tau, and phospho-tau in 3 of 4 carriers.","Increased Aβ43 and the Aβ42/Aβ40 ratio; decreased Aβ38, Aβ40, and Aβ42.",Exon 8,"Point, Missense",TGT to TTT
C263W,Alzheimer's Disease,AD : Pathogenic,"Unknown, but in one case, CSF biomarkers were consistent with AD and brain imaging revealed cortical atrophy in three cases.","Unknown, but 3D modeling suggested conformational effects and the PHRED-scaled CADD score was above 20 suggesting a deleterious effect.",Exon 8,"Point, Missense",TGT to TGG
P264L,"Alzheimer's Disease, Atypical Dementia, Progressive Nonfluent Aphasia, Spastic Paraparesis",AD : Pathogenic,"Variable: Neuropathology frequently consistent with a diagnosis of AD, but also significant white-matter abnormalities and severe cerebral amyloid angiopathy with numerous small cortical infarcts. Abundant cotton-wool plaques composed of Aβ42 have also been reported.","Increased Aβ42/Aβ40 and decreased Aβ38/Aβ42 ratios; increased Aβ42, and decreased Aβ40 and Aβ38 production; Deposition of PSEN-1 in the endoplasmic reticulum; impaired mitochondrial activity and ATP production.",Exon 8,"Point, Missense",CCG to CTG
G266S,"Alzheimer's Disease, Cerebral Amyloid Angiopathy, Spastic Paraparesis",AD : Pathogenic,"In one case, cotton-wool plaques; cerebral amyloid angiopathy; temporal and frontal lobe atrophy; widespread NFTs; reactive gliosis in white matter. MRI in another case revealed parietal lobe atrophy, frontal lobe deep white matter abnormalities. SPECT showed hypoperfusion of parietal and occipital areas.","Marked increase in Aβ42/Aβ40 ratio; reduced production of Aβ42, and particularly Aβ40, in vitro. ",Exon 8,"Point, Missense",GGT to AGT
P267S,Alzheimer's Disease,AD : Pathogenic,Neuropathology consistent with Alzheimer's disease.,Reduced γ-secretase activity; Increased cell cycle arrest.,Exon 8,"Point, Missense",CCA to TCA
P267A,Alzheimer's Disease,AD : Pathogenic,"Frequent neuritic plaques, including in the neocortex (Braak stage VI); Severe cerebral amyloid angiopathy.","Decreased Aβ37/Aβ42, increased Aβ42/Aβ40, and increased Aβ43 in cultured cells.",Exon 8,"Point, Missense",CCA to GCA
R269G,"Alzheimer's Disease, Myoclonus",AD : Likely Pathogenic,"Unknown, but in one patient, MRI showed mild, non-specific cortical atrophy and EEG revealed a moderate, bilateral excess of slow wave activity. SPECT imaging showed non-specific, moderate hypoperfusion of the posterior parietal cortex.",Decreased Aβ40 and Aβ42 production; increased Aβ42/Aβ40 ratio. ,Exon 8,"Point, Missense",CGT to GGT
R269H,"Alzheimer's Disease, Cerebral Amyloid Angiopathy, Myoclonus",AD : Likely Pathogenic,"Neuropathology consistent with Alzheimer's disease; a high burden of Aβ and neurofibrillary tangles in cortical areas. Prominent microbleeds in the cerebellum, parieto-occipital region, and temporal lobe revealed by MRI in one patient. MRI in two cases showed white matter alterations.",Decreased the Aβ (37 + 38 + 40) / (42 + 43) ratio in cells; decreased γ-secretase activity (53% of wildtype).,Exon 8,"Point, Missense",CGT to CAT
L271V,Alzheimer's Disease,AD : Pathogenic,"Considerable atrophy of the temporal and posterior white matter with enlargement of the lateral ventricles. Variant plaques: large, non-cored, reminiscent of cotton-wool plaques. Depigmented locus coeruleus.",,Exon 8,"Point, Missense",CTG to GTG
V272A,"Alzheimer's Disease, Parkinsonism, Subcortical Dementia",AD : Pathogenic,"Neuropathology consistent with AD, but also Lewy bodies in cortex and substantia nigra, and widespread subcortical neuritic lesions. MRI and PET abnormalities in subcortical-frontal areas in later stages of disease.","Increased plasma Aβ42. In vitro, increased Aβ42 production and Aβ42/Aβ40.",Exon 8,"Point, Missense",GTT to GCT
E273A,Alzheimer's Disease,AD : Pathogenic,Unknown,Increased Aβ43 and decreased Aβ38 in cells; increased Aβ42 and Aβ42/Aβ40 ratio in vitro; disrupted calcium flow in ER.,Exon 8,"Point, Missense",GAA to GCA
E273G,Alzheimer's Disease,AD : Likely Pathogenic,Unknown.,"Unknown, but multiple in silico algorithms predicted it is damaging.",Exon 8,"Point, Missense",GAA to GGA
A275V,Alzheimer's Disease,AD : Pathogenic,Neuropathology consistent with AD.,Increased the Aβ42/Aβ40 ratio and decreased the Aβ (37 + 38 + 40) / (42 + 43) ratio.,Exon 8,"Point, Missense",GCT to GTT
R278I,"Alzheimer's Disease, Progressive Nonfluent Aphasia","AD : Pathogenic, Progressive Nonfluent Aphasia : Not Classified","Neuropathology consistent with AD in two cases; with more Aβ deposition in the APOE3/4 carrier than the APOE2/3 carrier. Also, in the amygdala, α-synuclein pathology in both cases, and, in one case, TDP-43 pathology. ","Deficient maturation of mutant protein in iPSC-derived neurons. Selective increase in secreted Aβ43; impaired endoproteolysis of PSEN1. Increased Aβ42/Aβ40, Aβ42/Aβ38, and particularly Aβ43/Aβ40 ratios. Aβ38/Aβ40 ratio similar to wild-type.  Impaired processing of the ApoER2 LDL receptor. ",Exon 8,"Point, Missense",AGA to ATA
E280K,Alzheimer's Disease,AD : Pathogenic,"Unknown; MRI showed generalized brain atrophy, including atrophy of the hippocampus.",Unknown; predicted probably damaging in silico.,Exon 8,"Point, Missense",GAA to AAA
E280A,Alzheimer's Disease,AD : Pathogenic,"Neuropathology consistent with AD. Aβ42 abundant in the cerebral cortex, hippocampus, cerebellum, midbrain, and basal ganglia. Frequent CAA and cerebellar damage including ubiquitin–positive plaques, reactive astrocytes, and dystrophic neurites. Lewy body disease and TDP-43 pathology. Also, small vessel disease, disrupted gliovascular units, hyper-reactive astrocytes, and olfactory system alterations.","In cells, increased the Aβ42/Aβ40 ratio and decreased the Aβ (37 + 38 + 40) / (42 + 43) and Aβ37/Aβ42 ratios. Activation of chaperone-mediated autophagy. Deleterious effects on stress vulnerability with increased tau phosphorylation, and impairment of sodium channels, calcium homeostasis, mitochondrial function, AChE activity.",Exon 8,"Point, Missense",GAA to GCA
E280G,"Alzheimer's Disease, Spastic Paraparesis",AD : Pathogenic,Frequent cotton-wool plaques and vascular amyloid deposits; Some cases with white-matter abnormalities and degeneration of the corticospinal tract.,"Increased Aβ42/Aβ40 ratio in cells and in vitro. Aβ42 secretion was increased in cells, but production of both Aβ42 and Aβ40 was reduced in vitro, as was endoproteolytic processing of PSEN1.",Exon 8,"Point, Missense",GAA to GGA
L282V,"Alzheimer's Disease, Cerebral Amyloid Angiopathy",AD : Pathogenic,"Extensive neurofibrillary tangles and amyloid deposits including both dense-cored plaques and diffuse plaques. Severe cerebral amyloid angiopathy (CAA) in the neocortex, hippocampus, and cerebellum. CAA deposits associated with dystrophic neurites and inflammatory gliosis. Severe white-matter loss. Cerebellar amyloid pathology associated with severe CAA and loss of Purkinje cells.","Increased Aβ42/Aβ40 ratio and decreased Aβ37/Aβ42 ratio in cells. In vitro, Aβ42 and Aβ40 production, as well as Aβ42/Aβ40 ratio, similar to wild-type. Impairs trafficking of the APOE receptor apoER2.",Exon 8,"Point, Missense",CTT to GTT
L282F,Alzheimer's Disease,AD : Pathogenic,Unknown; MRI showed mild medial temporal atrophy. FDG-PET showed glucose hypometabolism in the bilateral parietal cortices and posterior cingulate gyri.,"Although Aβ42/Aβ40 was similar to controls, Aβ37/Aβ42 was decreased and Aβ43 levels were increased in a cell-based assay.",Exon 8,"Point, Missense",CTT to TTT
L282R,"Alzheimer's Disease, Parkinson's Disease",AD : Pathogenic,Neuropathology consistent with Alzheimer's disease.,Decreased Aβ (37 + 38 + 40) / (42 + 43) and Aβ37/Aβ42 ratios and increased Aβ43. The Aβ42/Aβ40 ratio was increased or unchanged.,Exon 8,"Point, Missense",CTT to CGT
F283L,"Alzheimer's Disease, Corticobasal Syndrome",AD : Pathogenic,"Neuropathology consistent with AD; absence of CBD pathology (2 cases in 1 family). MRI showed severe parietal, perirolandic, and temporal atrophy with relative sparing of frontal and ipsilateral hippocampal regions.","Unknown, but predicted to have a damaging effect according to SIFT, Polyphen, and Mutation Taster.",Exon 8,"Point, Missense",TTT to TTG
P284S,"Alzheimer's Disease, Ataxia, Spastic Paraparesis",AD : Likely Pathogenic,"Unknown, but in 4 family members, MRI revealed widespread white-matter lesions, with lobar microbleeds in two. In an unrelated carrier, PET showed Aβ deposition in cortex, cerebellum, and putamen and CSF biomarkers consistent with AD.",Aβ40 and Aβ42 production was similar to wild-type PSEN1 in vitro.,Exon 8,"Point, Missense",CCA to TCA
P284L,"Alzheimer's Disease, Spastic Paraparesis",AD : Likely Pathogenic,"Prominent cotton-wool plaques in the cerebral cortex, basal ganglia, brainstem, and spinal cord. Some dense core plaques, primarily in the hippocampus and cerebral cortex. Vacuolar changes. Amyloid angiopathy. Neurofibrillary tangles. Mild neuritic changes and gliosis.","Unknown, but several in silico algorithms predict it is damaging.",Exon 8,"Point, Missense",CCA to CTA
A285V,Alzheimer's Disease,AD : Likely Pathogenic,"Unknown, but MRI from 2 patients showed atrophy of the temporo-parietal cortex and hippocampus, and abnormalities in the deep white matter of the pariteo-occipital lobes. SPECT revealed hypoperfusion in parietal and occipital areas.","Aβ40 and Aβ42 levels similar to controls in CSF of one patient. In cells, Aβ42 production elevated compared to Aβ40 and Aβ38 production. In vitro, both Aβ40 and Aβ42 production modestly reduced; Aβ42/Aβ40 similar to wild-type PSEN1.",Exon 8,"Point, Missense",GCT to GTT
L286V,Alzheimer's Disease,AD : Pathogenic,Neuropathology consistent with AD.,"Increased Aβ42/Aβ total ratio, unchanged Aβ42/Aβ40 ratio, and increased Aβ43, Aβ42, and Aβ40 levels, with decreased non-amylodiogenic processing of APP in cells. In vitro, decreased ε-cleavage. Disrupts intracellular calcium dynamics and cellular redox status.",Exon 8,"Point, Missense",CTC to GTC
L286P,"Alzheimer's Disease, Cerebral Amyloid Angiopathy",AD : Pathogenic,Cotton wool plaques and severe amyloid angiopathy (2 cases); brain hematoma at early age (3 cases).,"Decreased Aβ37, Aβ38, Aβ39, and Aβ42 in patient CSF; increased Aβ15 and Aβ20. Increased Aβ42/43 amyloid production in cultured cells; reduced production rates of Aβ38 and Aβ40 in isolated brain membranes, and decreased Aβ38/Aβ42 ratio.",Exon 8,"Point, Missense",CTC to CCC
Y288H,"Alzheimer's Disease, Dementia, Spastic Paraparesis, Parkinsonism",AD : Pathogenic,"Unknown, but increased levels of Aβ42 and an elevated Aβ42/Aβ40 ratio in serum. Also, high incidence of cerebral microhemorrhages in multiple carriers.","Increased the Aβ42/Aβ40 ratio in cells, but Aβ42 levels were unchanged; Aβ40 levels were reduced.",Exon 8,"Point, Missense",TAC to CAC
T291P,"Alzheimer's Disease, Spastic Paraparesis",AD : Likely Pathogenic,"Unknown; MRI showed marked diffuse atrophy and a signal in the right temporal lobe, compatible with previous bleeding.","In cells, this mutation increased both Aβ40 and Aβ42, causing an overall increase in the Aβ42/Aβ40 ratio. However, in an in vitro assay, it dramatically decreased Aβ42 and abolished Aβ40 production. Also affects exon 9 splicing.",Exon 9,"Point, Missense",ACA to CCA
R377W,Alzheimer's Disease,AD : Likely Pathogenic,"Unknown; in one case, imaging showed amyloid deposition in the precuneus and frontal and parietal areas, with mild parietal atrophy and hypometabolism in precuneus, posterior cingulum, inferior parietal lobes, temporal, and frontal lobes. Frontotemporal atrophy and hypometabolism seen in another case.","In vitro, decreased Aβ42 production and abrogated Aβ40 production.",Exon 10,"Point, Missense",AGG to TGG
R377M,Alzheimer's Disease,AD : Likely Pathogenic,Unknown,"Unknown, but in silico algorithm predicted it is deleterious (PHRED-scaled CADD = 32).",Exon 11,"Point, Missense",AGG to ATG
G378E,"Alzheimer's Disease, Cerebral Amyloid Angiopathy",AD : Pathogenic,Neuropathology consistent with AD. One case also had notable cerebral amyloid angiopathy.,Increased Aβ42/Aβ40 ratio; increased Aβ42.,Exon 11,"Point, Missense",GGA to GAA
G378V,Alzheimer's Disease,AD : Pathogenic,Neuropathology consistent with AD.,"Decreased Aβ42 and abrogation of Aβ40 production in vitro. Predicted to have a damaging effect by SIFT, Polyphen, and Mutation Taster.",Exon 11,"Point, Missense",GGA to GTA
L381V,"Alzheimer's Disease, Spastic Paraparesis",AD : Pathogenic,"Unknown, but in one carrier, PET revealed widespread amyloid and tau pathology, atrophy, hypometabolism, and reduced dopamine transporter in the putamen. In another, Aβ38 and Aβ40 in CSF were proportionately reduced while Aβ43 was relatively high resulting in an elevated Aβ43/Aβ42 ratio.","Increased Aβ42/Aβ40 ratio; increased Aβ42 and Aβ43; Reduced PSEN1 N-terminal fragment (NTF), suggesting impaired endoproteolysis of PSEN1.",Exon 11,"Point, Missense",CTT to GTT
L381F,Alzheimer's Disease,AD : Pathogenic,"Neuropathology consistent with AD, including neuritic amyoid plaques and neurofibrillary tangles. Hirano bodies and granulovacuolar degeneration in the hippocampus.",In silico analysis suggests that the mutation affects the folding free energy and flexibility of the protein.,Exon 11,"Point, Missense",CTT to TTT
G384A,Alzheimer's Disease,AD : Pathogenic,Neuropathology consistent with AD.,Increased Aβ42/Aβ40 ratio and reduced Aβ (37 + 38 + 40) / (42 + 43) and Aβ37/Aβ42 ratios. Abolished ER calcium leak channel activity and reduced ApoE secretion. Altered subcellular localization of PSEN1 and its interaction with GLT-1.,Exon 11,"Point, Missense",GGA to GCA
F386I,Alzheimer's Disease,AD : Pathogenic,Unknown; MRI showed atrophy of hippocampus.,Increased Aβ42/Aβ40 and Aβ43; decreased Aβ37/Aβ42 in cells.,Exon 11,"Point, Missense",TTC to ATC
F386S,Alzheimer's Disease,AD : Pathogenic,Unknown,Decreased Aβ37/Aβ42 ratio and dramatically increased Aβ43 in cells. Increased Aβ42/Aβ40 ratio in 3 assays.,Exon 11,"Point, Missense",TTC to TCC
F386L,Alzheimer's Disease,AD : Pathogenic,Unknown.,"Unknown, but predicted to be pathogenic by multiple in silico analyses.",Exon 11,"Point, Missense",TTC to TTA
F388S,"Alzheimer's Disease, Spastic Paraparesis",AD : Pathogenic,"Unknown, but MRI revealed brainstem atrophy, and DTI showed corticospinal tract abnormalities typical of spastic paraparesis.","Unknown, but cryo-EM data and in silico algorithms suggest it is damaging.",Exon 11,"Point, Missense",TTC to TCC
F388L,Alzheimer's Disease,AD : Pathogenic,Unknown.,Increased Aβ42 and Aβ42/Aβ40 ratio.,Exon 11,"Point, Missense",TTC to TTG
Y389H,"Alzheimer's Disease, Parkinsonism",AD : Likely Pathogenic,"Unknown, but in two cases, amyloid-PET was positive. MRI revealed mild, diffuse cortical atrophy in one case, and severe frontotemporal atrophy in another. FDG-PET showed bilateral hypometabolism in parietal and temporal cortices in one case. ","Unknown, but in silico algorithms predicted probably damaging (Polyphen2) and not tolerable/damaging (SIFT). CADD score = 26.9.",Exon 11,"Point, Missense",TAC to CAC
V391F,Alzheimer's Disease,AD : Pathogenic,Unknown,Increased Aβ42/Aβ40 ratio; reduced Aβ40 production in vitro.,Exon 11,"Point, Missense",GTT to TTT
V391G,Alzheimer's Disease,"AD : Pathogenic, Parkinsonism : Not Classified","Unknown; in single case MRI showed generalized mild cortical and subcortical atrophy, thinner hippocampus, and enlarged ventricles.","Unknown, probable damaging as predicted by multiple in silico algorithms. Phenotype complicated by family history of extrapyramidal disease with several associated recessive mutations (PANK2, SYNE1, ZNF592)",Exon 11,"Point, Missense",GTT to GGT
L392V,Alzheimer's Disease,AD : Pathogenic,"Neuropathology consistent with AD, including cortical atrophy, amyloid plaques, and neurofibrillary tangles.","Increased Aβ42:Aβ40 ratio; increased Aβ48-39 production line, including Aβ42, in cells; decreased Aβ40 production in vitro. Impaired Notch cleavage. ",Exon 11,"Point, Missense",CTG to GTG
G394V,Alzheimer's Disease,AD : Likely Pathogenic,Unknown,"In vitro, Aβ40 production undetectable; Aβ42 drastically reduced; autoproteolysis abrogated. Four algorithms predicted the mutation to be damaging, with a PHRED-CADD score of 31. In patient cells with additional mutation (E318G), no change in Aβ40 or Aβ42 levels.",Exon 11,"Point, Missense",GGT to GTT
K395I,Alzheimer's Disease,AD : Likely Pathogenic,"Neuropathological data are unavailable. No abnormalities were detected in an early MRI scan of the proband’s brain, nor in an EEG.",Increased Aβ42/Aβ40 ratio and decreased both Aβ42 and Aβ40 levels.,Exon 11,,AAA to ATA
A396T,Alzheimer's Disease,AD : Likely Pathogenic,"Neuropathology was consistent with AD, plus widespread α-synuclein inclusions characteristic of Lewy body disease, in one case. MRI of another case showed atrophy of the frontal lobes.",Increased Aβ40 and Aβ42 production with Aβ42/Aβ40 ratio unchanged in cells; reduced Aβ40 production and increased Aβ42/Aβ40 ratio in vitro. ,Exon 11,"Point, Missense",GCC to ACC
C410Y,Alzheimer's Disease,AD : Pathogenic,Neuropathology consistent with AD.,Increased Aβ42/Aβ total ratio and decreased Aβ (37 + 38 + 40) / (42 + 43) ratio in cells. Dominant-negative inhibition of wild-type PSEN1. Partial loss of γ-secretase cleavage of Notch and β-neurexin.,Exon 11,"Point, Missense",TGT to TAT
I416T,Alzheimer's Disease,AD : Pathogenic,"Unknown, but two cognitively normal mutation carriers had preclinical amyloid plaques and tau accumulation, as assessed by PET, similar to those of individuals at-risk for late-onset AD or individuals carrying other AD-causing PSEN1 mutations.","Unknown, but mutation results in the substitution of a highly conserved, transmembrane, hydrophobic amino acid with a polar amino acid near a splice site. CADD score >20.",Exon 11,"Point, Missense",ATT to ACT
L418F,Alzheimer's Disease,AD : Likely Pathogenic,Unknown,"Decreased Aβ40 and Aβ42 production, and elevated Aβ42/Aβ40 ratio, in vitro.",Exon 12,"Point, Missense",TTG to TTT
L420R,Alzheimer's Disease,AD : Likely Pathogenic,"Extensive amyloid pathology, primarily in the form of cotton-wool plaques, although some rare dense core plaques. Some amyloid angiopathy.",Decreased Aβ40 and Aβ42 production; increased Aβ42/Aβ40 ratio in vitro.,Exon 12,"Point, Missense",CTT to CGT
L424F,"Alzheimer's Disease, Dementia, Depression",AD : Pathogenic,"Unknown, but neuroimaging in two patients revealed brain atrophy with white-matter changes.",Increased Aβ42/Aβ40 and decreased Aβ37/Aβ42 in cultured cells.,Exon 12,"Point, Missense",CTC to TTC
L424H,"Alzheimer's Disease, Atypical Dementia",AD : Pathogenic,Unknown; generalized cerebral atrophy by MRI; diffuse cerebral hypoperfusion by SPECT.,Increased Aβ42/Aβ40 and Aβ43; decreased Aβ37/Aβ42.,Exon 12,"Point, Missense",CTC to CAC
L424R,"Alzheimer's Disease, Spastic Paraparesis",AD : Pathogenic,Unknown; MRI showed cortical and subcortical atrophy with a thin corpus callosum.,"Increased Aβ42/Aβ40 and Aβ43 levels, and decreased Aβ37/Aβ42.",Exon 12,"Point, Missense",CTC to CGC
L424P,Alzheimer's Disease,AD : Likely Pathogenic,"Unknown, but in proband, MRI showed medial temporal lobe atrophy and global cortical atrophy; PET showed hypometabolism in parietal areas, the precuneus, and the posterior cingulate cortex. Also, reduced CSF Aβ42.","Unknown, but predicted pathogenic by multiple in silico algorithms. 3D in silico analysis predicted shortening of two intramembrane α-helices and creation of a new one.",Exon 12,"Point, Missense",CTC to CCC
A426P,Alzheimer's Disease,AD : Pathogenic,"Unknown, but PiB-PET revealed robust amyloid deposition in the striatum. PiB retention was also found in the neocortex and thalamus. Compared to sporadic AD, amyloid accumulation in frontal, temporoparietal, and precuneus cortices was lower.","Aβ42/Aβ40 ratio increased, Aβ (37 + 38 + 40) / (42 + 43) ratio decreased in cells. γ-secretase composite score (% relative to wildtype) = 52.86 ",Exon 12,"Point, Missense",GCC to CCC
A431E,Alzheimer's Disease,"AD : Pathogenic, SP : Pathogenic","Neuropathology consistent with AD. Widespread white-matter abnormalities in several patients with motor impairments, high incidence of cerebral microhemorrhages. In one case, Lewy body pathology.",Aβ42/Aβ40 ratio increased in vitro and Aβ (37 + 38 + 40) / (42 + 43) decreased in cultured cells. Toxic peptide Aβ43 was particularly elevated. Increased expression of cell cycle genes and activation of REST in iPSC-neurons. Enhanced MAO-A activity in HT-22 cells.,Exon 12,"Point, Missense",GCA to GAA
A431V,Alzheimer's Disease,AD : Likely Pathogenic,"Unknown, but in one case FDG-PET at MCI-AD stage showed low metabolic rates in posterior cingulate gyrus, posterior and lateral parietal cortices, and medial temporal regions; elevated tau and phospho-tau in CSF.",Unknown. Multiple in silico algorithms predicted damaging.,Exon 12,"Point, Missense",GCA to GTA
P433S,Alzheimer's Disease,AD : Pathogenic,Unknown,"Increased Aβ42, Aβ43, and Aβ42/Aβ40 ratio in transfected cells. Reduced PSEN1 endoproteolysis.",Exon 12,"Point, Missense",CCA to TCA
A434T,"Alzheimer's Disease, Parkinsonism",AD : Pathogenic,Unknown.,Unknown; predicted damaging in silico.,Exon 12,"Point, Missense",GCT to ACT
A434C,Alzheimer's Disease,AD : Pathogenic,"Numerous diffuse plaques and neuritic plaques with dense amyloid cores throughout the neocortex; Abundant neurofibrillary tangles and Hirano bodies; Moderate cell loss and gliosis in the hippocampus, amygdala, and nucleus basalis.","Increased Aβ42 and decreased Aβ40 production in vitro, resulting in an increased Aβ42/Aβ40 ratio.",Exon 12,"Point, Double",GCT to TGT
L435F,Alzheimer's Disease,AD : Pathogenic,"Widespread cotton-wool plaques in the neocortex, hippocampus, and deep cerebral nuclei contain substantially more Aβ43 than typical plaques. Abundant neurofibrillary tangles in the entorhinal cortex and hippocampus. Mild cerebral amyloid angiopathy. Neuronal loss, depigmentation, and gliosis in the substantia nigra.","Elevated Aβ43 in cells, inluding iPSC-derived neurons, knockin rats, and human brain tissue (although decreased Aβ43 in knockin mice). Decreased total Aβ, Aβ42, Aβ40, APP-CTF. Decreased ε-cleavage, autoproteolysis, and Aβ46→Aβ43 and Aβ43→Aβ40 trimming. Altered Notch function. Impaired wildtype PSEN1 γ-secretase activity. Increased seeding and propagation of tau aggregates.",Exon 12,"Point, Missense",CTT to TTT
P436S,"Alzheimer's Disease, Spastic Paraparesis",AD : Pathogenic,"Consistent with AD in one carrier, with both dense-core (Aβ43+) and cotton wool amyloid plaques. Lewy body pathology mostly in the amygdala.","Increased Aβ43/Aβ40 and Aβ42/Aβ40 ratios. Unlike other PSEN1 mutations, unchanged Aβ42/Aβ38 ratio. Autoproteolytic processing similar to wildtype PSEN1.",Exon 12,"Point, Missense",CCA to TCA
P436Q,"Alzheimer's Disease, Spastic Paraparesis",AD : Pathogenic,"Neuropathology consistent with AD in at least one mutation carrier, including frequent Aβ plaques, many of the cotton-wool type, and severe neurofibrillary tangle pathology (Braak and Braak stage VI).","Increased the Aβ42/Aβ40 ratio in cells, while reducing production of Aβ40, Aβ42, and APP and Notch intracellular domains. Also reduced autoproteolytic processing of PSEN1.",Exon 12,"Point, Missense",CCA to CAA
I437V,Alzheimer's Disease,AD : Likely Pathogenic,Unknown.,"Decreased Aβ40 and Aβ42 production, and increased Aβ42/Aβ40 ratio in vitro.",Exon 12,"Point, Missense",ATC to GTC
